Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine.
about
Synthetic teichoic acid conjugate vaccine against nosocomial Gram-positive bacteriaThe SaeRS Two-Component System Controls Survival of Staphylococcus aureus in Human Blood through Regulation of Coagulase.Multiple B-cell epitope vaccine induces a Staphylococcus enterotoxin B-specific IgG1 protective response against MRSA infectionTeichoic acids: synthesis and applications.Streamlined synthesis and evaluation of teichoic acid fragments.Potential targets for next generation anti-microbial glycoconjugate vaccines.
P2860
Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine.
@en
type
label
Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine.
@en
prefLabel
Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine.
@en
P2093
P2860
P356
P1476
Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine
@en
P2093
Andrew Lees
Clifford M Snapper
David Schwartz
Goutam Sen
James J Mond
Jay Dintaman
Mark E Shirtliff
Quanyi Chen
Saeyoung Park
P2860
P304
P356
10.1128/IAI.00271-13
P407
P50
P577
2013-05-06T00:00:00Z